Home / Piperacillin and Beta-Lactamase Inhibitor / Switzerland
CH ATC J01CR05 · updated 2 Nov 2026
Piperacillin and Beta-Lactamase Inhibitor shortage in Switzerland
Is there a Piperacillin and Beta-Lactamase Inhibitor shortage in Switzerland?
Yes. As of 2 Nov 2026, 1 Piperacillin and Beta-Lactamase Inhibitor product is reported short in Switzerland, the first since 9 Oct 2026. The company estimate for the return is 15 Dec 2026. Main reason: not stated.
Also short in United States, Canada, Italy, Belgium, Czechia, Sweden, Japan. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | PIPERACILLIN TAZOB. Labatec 4.5 g Durchstf PIPERACILLIN TAZOB. Labatec 4.5 g Durchstf 10 Stk | Labatec Pharma SA | 9 Oct 2026 | 15 Dec 2026 | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).